Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 43.38
1.95 %
$ 5.35 B
Market Cap
-12.19
P/E
Price Target
Average
--13.32%
Revenue Forecast
Estimate
25.41%
EBIT
Estimate
--38.07%
Net Income
Estimate
18.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Guardant Health, Inc.
Wall Street analysts predict an average 1-year price target for GH of $37.6 , with forecasts ranging from
a
low of
$28 to a high of $50 .
GH Lowest Price Target
Wall Street Target
28 USD
-35.45%
GH Average Price Target
Wall Street Target
37.6 USD
-13.32%
GH Highest Price Target
Wall Street Target
50 USD
15.26%
REVENUE FORECAST
Revenue Forecast Chart GH
EBIT FORECAST
EBIT Forecast Chart GH
NET INCOME FORECAST
Net Income Chart GH